chrX-126165114-T-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001013628.3(DCAF12L2):āc.811A>Gā(p.Ser271Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000396 in 1,210,591 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 172 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001013628.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DCAF12L2 | NM_001013628.3 | c.811A>G | p.Ser271Gly | missense_variant | 1/1 | ENST00000360028.4 | NP_001013650.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DCAF12L2 | ENST00000360028.4 | c.811A>G | p.Ser271Gly | missense_variant | 1/1 | 6 | NM_001013628.3 | ENSP00000353128.2 |
Frequencies
GnomAD3 genomes AF: 0.000399 AC: 45AN: 112872Hom.: 0 Cov.: 24 AF XY: 0.000342 AC XY: 12AN XY: 35038
GnomAD3 exomes AF: 0.000479 AC: 87AN: 181572Hom.: 0 AF XY: 0.000376 AC XY: 25AN XY: 66474
GnomAD4 exome AF: 0.000395 AC: 434AN: 1097719Hom.: 0 Cov.: 36 AF XY: 0.000441 AC XY: 160AN XY: 363105
GnomAD4 genome AF: 0.000399 AC: 45AN: 112872Hom.: 0 Cov.: 24 AF XY: 0.000342 AC XY: 12AN XY: 35038
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 08, 2023 | The c.811A>G (p.S271G) alteration is located in exon 1 (coding exon 1) of the DCAF12L2 gene. This alteration results from a A to G substitution at nucleotide position 811, causing the serine (S) at amino acid position 271 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | DCAF12L2: BP4, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at